Shanghai Model Organisms Center(SH:688265)2025-01-17 10:55Revenue Forecast - The company expects 2024 annual revenue to be between 370 million and 390 million CNY, representing a year-on-year increase of 0.94% to 6.40%[3]. - The company achieved a slight increase in revenue due to stable growth in domestic research customer demand and rapid growth in overseas business revenue[10]. Profit Forecast - The net profit attributable to the parent company is projected to be between 5 million and 7.5 million CNY, an increase of 25.58 million to 28.08 million CNY compared to the previous year[5]. - The net profit attributable to the parent company, excluding non-recurring gains and losses, is expected to be between -26 million and -13 million CNY, an improvement of 13.51 million to 26.51 million CNY year-on-year[5]. - The company reported a total profit of -29.90 million CNY for 2023, with a net profit attributable to the parent company of -20.58 million CNY[10]. Cost Management - The company has strengthened cost control and implemented comprehensive budget management, resulting in slight cost reduction and efficiency improvement[10]. Non-Recurring Gains - Non-recurring gains such as financial income and government subsidies increased year-on-year during the reporting period[10]. Performance Forecast Uncertainties - The company has not identified any significant uncertainties affecting the accuracy of the performance forecast[8]. - The performance forecast data is preliminary and subject to final audited results in the 2024 annual report[9]. - The company emphasizes the importance of investor awareness regarding investment risks related to the preliminary forecast[9].